Patton Rebekah, Cook Jane, Haraldsdottir Erna, Brown Duncan, Dolan Ross D, McMillan Donald C, Skipworth Richard J E, Fallon Marie, Laird Barry J A
St Columba's Hospice, Edinburgh, United Kingdom.
Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom.
PLoS One. 2021 Dec 16;16(12):e0261175. doi: 10.1371/journal.pone.0261175. eCollection 2021.
There is a pressing need for a holistic characterisation of people with incurable cancer. In this group, where quality of life and improvement of symptoms are therapeutic priorities, the physical and biochemical manifestations of cancer are often studied separately, giving an incomplete picture. In order to improve care, spur therapeutic innovation, provide meaningful endpoints for trials and set priorities for future research, work must be done to explore how the tumour influences the clinical phenotype. Characterisation of the host-tumour interaction may also provide information regarding prognosis, allowing appropriate planning of investigations, treatment and referral to palliative medicine services.
Routine EValuatiOn of people LivIng with caNcer (REVOLUTION) is a prospective observational study that aims to characterise people with incurable cancer around five key areas, namely body composition, physical activity, systemic inflammatory response, symptoms, and quality of life by developing a bio-repository. Participants will initially be recruited from a single centre in the UK and will have assessments of body composition (bio-impedance analysis [BIA] and computed tomography [CT]), assessment of physical activity using a physical activity monitor, measurement of simple markers of inflammation and plasma cytokine proteins and three symptom and quality of life questionnaires.
This study aims to create a comprehensive biochemical and clinical characterisation of people with incurable cancer. Data in this study can be used to give a better understanding of the 'symptom phenotype' and quality of life determinants, development of a profile of the systemic inflammatory response and a detailed characterisation of body composition.
对于无法治愈的癌症患者,迫切需要进行全面的特征描述。在这一群体中,生活质量和症状改善是治疗的重点,癌症的身体和生化表现往往被分开研究,从而导致信息不完整。为了改善护理、推动治疗创新、为试验提供有意义的终点指标并确定未来研究的重点,必须开展工作来探索肿瘤如何影响临床表型。宿主与肿瘤相互作用的特征描述也可能提供有关预后的信息,从而有助于合理规划检查、治疗以及转诊至姑息医学服务机构。
癌症患者常规评估(REVOLUTION)是一项前瞻性观察性研究,旨在通过建立生物样本库,围绕五个关键领域对无法治愈的癌症患者进行特征描述,这五个领域分别是身体成分、身体活动、全身炎症反应、症状以及生活质量。参与者最初将从英国的一个单一中心招募,并将接受身体成分评估(生物电阻抗分析[BIA]和计算机断层扫描[CT])、使用身体活动监测器评估身体活动、测量炎症的简单标志物和血浆细胞因子蛋白,以及填写三份症状和生活质量问卷。
本研究旨在对无法治愈的癌症患者进行全面的生化和临床特征描述。本研究中的数据可用于更好地理解“症状表型”和生活质量的决定因素、建立全身炎症反应的概况以及详细描述身体成分。